Advancements in Analytical Quality Control for Biological Therapeutics

Key Learning Objectives

• Gain actionable insights into applying HT-SPR and KinExA technologies, as well as fluorescence and light scattering, for analytical quality control of antibodies and biologics.
• Explore innovative technologies and methodologies advancing biologic characterization and assessment.
• Discover new applications of SPR and KinExA in antibody screening, epitope binning, biosimilar comparability, and regulatory compliance.
• Engage with leading experts and instrument providers to discuss troubleshooting, assay optimization, and emerging trends in SPR and KinExA technologies.
• Explore high-throughput solutions for biophysical characterization to ensure the quality, quantity, and stability of biologics.

ACROBiosystems is a cornerstone enterprise of the pharmaceutical and biotechnology industries. Our mission is to help overcome challenges with innovative tools and solutions from discovery to the clinic. We supply life science tools designed to be used in discovery research and scalable to the clinical phase and beyond. By consistently adapting to new regulatory challenges and guidelines, we deliver solutions, whether it comes through recombinant proteins, antibodies, assay kits, GMP-grade reagents, or custom services. We empower scientists and engineers dedicated towards innovation to simplify and accelerate the development of new, better, and more affordable medicine.